The IMF’s Black Swan Research Initiative has changed the way we look at multiple myeloma. Six years ago, the original team, led by IMF Chairman Brian G.M. Durie, MD, concluded that the only way to cure the disease was to be able to identify it – and treat it vigorously – before it was too late. Flash ahead to 2019, and the BSRI has made tremendous progress, with more than 50 sites around the world where investigators are implementing MRD testing into their clinical trials.  “We can talk about the potential for curing myeloma, because we are so close, and we feel that we are, in fact, already most likely curing  patients in the cure trials,” says Dr. Durie. “We have ideas and ways to expand the percentage of patients who are curable, which is just truly remarkable.”

Previous Post
What is a BiTE and how likely is it to help me to achieve a response and remission for my myeloma?
Next Post
Is the combination of Velcade, Revlimid, and dexamethasone (VRd) helpful for myeloma patients over the age of 65?

Give Where Most Needed

We use cookies on our website to support technical features that enhance your user experience.

We also use analytics & advertising services. To opt-out click for more information.